Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q9UIJ5 (
Rec
)
58,342
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A new monoclonal antibody (mAb) that recognizes alpha-tropomyosin in cardiac muscle cells was used in a qualitative (polyacrylamide gel electrophoresis and indirect immunofluorescence) and quantitative (fluorescence-activated cell sorting) study of the expression of this protein during heart development. alpha-Tropomyosin expression was weak in early stages of chick embryo development (Hamburger and Hamilton stage 18), and increased steadily until Hamburger Hamilton stage 40. In early stages, the protein was found mainly in cytoplasm, whereas by the final stages, it was more abundant in the cytoskeletal compartment. The mAb cross-reacted with alpha-tropomyosin in smooth and striated muscle cells from chickens, mice, and humans, but did not cross-react with nonmuscle
tropomyosin
.
Anat
Rec
1992 Nov
PMID:Expression of alpha-tropomyosin during cardiac development in the chick embryo. 144 59
Actin, alpha-actinin, and
tropomyosin
were localized in the testicular, epididymal, and ejaculated spermatozoa and in the epithelium of the bovine epididymis by means of specific antibodies using an indirect immunofluorescence technique. Immunocytochemical results were confirmed by the western blot analysis. Independent of the method of fixation, washing, or sonication, actin, alpha-actinin, and
tropomyosin
were all consistently localized in the neck of the spermatozoa. Actin and
tropomyosin
present in the postacrosomal area could be removed by sonication, whereas alpha-actinin in the basal plate appeared to be resistant to the treatment. In the unwashed spermatozoa alpha-actinin-specific immunofluorescence was seen over the acrosomal area, whereas in the washed sperm it appeared as a narrow cap at the margin of the head. In the latter location, its distribution was similar to that of
tropomyosin
. In the majority of preparations,
tropomyosin
could be localized in the principal piece of the tail. Even though some actin-specific immunofluorescence could be identified in the principal piece of the tail of the testicular and epididymal spermatozoa, a strong immunoreaction appeared only in the ejaculated spermatozoa. In the principal cells of the epididymal epithelium, specific fluorescence for actin, alpha-actinin, and
tropomyosin
occurred in the apical junctional complex. Basal bodies of the solitary cilia of the epididymal epithelium were labelled with antitropomyosin and anti-alpha-actinin antibodies. Besides offering new information about the cytoskeletal composition of the mammalian sperm, the present results support the hypothesized homology between the connecting piece of the sperm neck and the basal body of the cilia.
Anat
Rec
1992 May
PMID:Localization of actin, alpha-actinin, and tropomyosin in bovine spermatozoa and epididymal epithelium. 160 79
The nematode Caenorhabditis elegans has been used as a valuable system to study structure and function of striated muscle. The body wall muscle of C. elegans is obliquely striated muscle with highly organized sarcomeric assembly of actin, myosin, and other accessory proteins. Genetic and molecular biological studies in C. elegans have identified a number of genes encoding structural and regulatory components for the muscle contractile apparatuses, and many of them have counterparts in mammalian cardiac and skeletal muscles or striated muscles in other invertebrates. Applicability of genetics, cell biology, and biochemistry has made C. elegans an excellent system to study mechanisms of muscle contractility and assembly and maintenance of myofibrils. This review focuses on the regulatory mechanisms of structure and function of actin filaments in the C. elegans body wall muscle. Sarcomeric actin filaments in C. elegans muscle are associated with the troponin-
tropomyosin
system that regulates the actin-myosin interaction. Proteins that bind to the side and ends of actin filaments support ordered assembly of thin filaments. Furthermore, regulators of actin dynamics play important roles in initial assembly, growth, and maintenance of sarcomeres. The knowledge acquired in C. elegans can serve as bases to understand the basic mechanisms of muscle structure and function.
Anat
Rec
(Hoboken) 2014 Sep
PMID:Regulation of structure and function of sarcomeric actin filaments in striated muscle of the nematode Caenorhabditis elegans. 2512 69
The
tropomyosin
(TM) gene family produces a set of related TM proteins with important functions in striated and smooth muscle, and nonmuscle cells. In vertebrate striated muscle, the thin filament consists largely of actin, TM, the troponin (Tn) complex (Tn-I, Tn-C and Tn-T), and tropomodulin (Tmod) and is responsible for mediating Ca(2+) control of muscle contraction and relaxation. There are four known genes (designated as TPM1, TPM2, TPM3, and TPM4) for TM in vertebrates. The four TM genes generate a multitude of tissue- and developmental-specific isoforms through the use of different promoters, alternative mRNA splicing, different 3'-end mRNA processing and tissue-specific translational control. In this review, we have focused mainly on the regulation of TM expression in striated muscles, primarily in vertebrate hearts with special emphasis on translational control using mouse and Mexican axolotl animal models.
Anat
Rec
(Hoboken) 2014 Sep
PMID:Translational control of tropomyosin expression in vertebrate hearts. 2512 72
Nerve growth factor (NGF) is essential for the survival of sensory and sympathetic neurons during development. However, in the adult, NGF and its interaction with
tropomyosin
receptor kinase A receptor (TrkA) has been found to play a critical role in nociception and nervous system plasticity in pain conditions. Thus, various monoclonal antibody (mAb) therapies targeting this pathway have been investigated in the development of new pharmacotherapies for chronic pain. Although none of the mAbs against NGF are yet approved for use in humans, they look very promising for the effective control of pain. Recently, species-specific anti-NGF mAbs for the management of osteoarthritis (OA)-associated pain in dogs and cats has been developed, and early clinical trials have been conducted. Anti-NGF therapy looks to be both very effective and very promising as a novel therapy against chronic pain in dogs and cats. This review outlines the mechanism of action of NGF, the role of NGF in osteoarthritis, research in rodent OA models and the current status of the development of anti-NGF mAbs in humans. Furthermore, we describe and discuss the recent development of species-specific anti-NGF mAbs for the treatment of OA-associated pain in veterinary medicine.
Vet
Rec
2019 Jan 05
PMID:Anti-nerve growth factor monoclonal antibodies for the control of pain in dogs and cats. 3060 56